Sezzle Pullback May Improve Valuation, but Underlying Risks Unchanged
Read source articleWhat happened
Sezzle's stock has experienced a sharp pullback following its Q2 earnings, prompting a Zacks article suggesting that the valuation setup has improved due to continued rapid revenue, subscriber, and earnings growth. However, the deep value master report, based on detailed financial analysis, rates the stock as a potential sell at $77, citing elevated multiples, increasing reliance on consumer fees, and rising credit costs. The article does not address these underlying risks, instead focusing on growth momentum and the lower share price as a buying opportunity. The pullback may have reduced some froth, but the core issues of regulatory uncertainty and credit quality remain unresolved. Investors should view the promotional article critically against the more comprehensive risk assessment.
Implication
The article's positive tone likely reflects sell-side optimism rather than a fundamental improvement in risk. The master report’s bear case of $55 and base case of $80 imply limited upside even if growth continues, while downside risk from credit deterioration or fee caps could be severe. The sharp pullback may have improved the risk-reward slightly, but the stock still trades at high multiples for a business with short-duration, unsecured consumer credit. Investors should monitor upcoming earnings for signs of credit normalization and regulatory news before considering entry. A disciplined approach suggests waiting for a price below the master report's attractive entry of $60 or clear evidence of fee-light growth before adding.
Thesis delta
The new article suggests that the post-Q2 pullback has improved the valuation setup, but this is a qualitative opinion without updated financials. It does not alter the core thesis from the master report that the stock is overpriced relative to underlying risks. Therefore, the thesis remains potential sell, with the pullback possibly creating a better entry for short-term traders but not changing the long-term risk profile.
Confidence
medium